by DiaCarta Inc. | Jul 31, 2018 | Press Releases
Press release BlogConferencesPress ReleasesWebinars & VideosPublications Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ July ❯ DiaCarta Named to MedTech Outlook’s Top 10 In-Vitro Diagnostic Technology Solution Providers 2018 FollowFollowFollow...
by DiaCarta Inc. | Jul 2, 2018 | Press Releases
Press release BlogConferencesPress ReleasesWebinars & VideosPublications Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ July ❯ DiaCarta Inc. Appoints Arrow Diagnostics as Exclusive Distributor for ColoScape™ in Italy FollowFollowFollow DiaCarta Inc...
by Media Coverage | Jul 2, 2018 | Blog
Month: July 2018 FollowFollowFollow At a pathology lab, a researcher is working on a patient’s blood sample to extract cell-free DNA to find the potential diagnostic biomarker for cancers. Using the current DNA sequencing techniques such as next-generation sequencing...
by DiaCarta Inc. | Jul 2, 2018 | Blog
Month: July 2018 FollowFollowFollow 1. The challenges that our clients faced Acute myeloid leukemia (AML) is an aggressive hematopoietic neoplasm characterized by an accumulation of myeloid cells in the bone marrow because of impaired differentiation and...
by Media Coverage | Jul 1, 2018 | Blog
Month: July 2018 FollowFollowFollow Headquartered in Richmond, California with an ISO 13485 and CLIA certified facility, DiaCarta develops, manufactures, and markets cancer research and IVD products and performs molecular testing ‘liquid biopsy’ services for precision...
Recent Comments